drugset / Trial / NCT04361162
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
Phase 2
Active not recruiting
30 enrolled
Massachusetts General Hospital
Bristol-Myers Squibb · collab
NaSingle-groupOpen-labelTreatment
Summary
This research is being done to study the effects of the combination of ipilimumab, nivolumab, and radiation therapy in people with microsatellite stable pancreatic cancer. The names of the study interventions involved in this study are: * Ipilimumab * Nivolumab * Radiation Therapy
Timeline
- Start
- 2020-05-18
- Primary completion
- 2022-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipilimumab | Monoclonal antibody | — | Intravenous |
| Subject | Nivolumab | Monoclonal antibody | — | Intravenous |